title: Intelligent pharmaceuticals: beyond the tipping point.
abstract: Confluences of key factors can transform apparently isolated or random events into trends. The ongoing and growing pressures facing the pharmaceutical industry have "tipped" the industry toward a new direction in the choice of which new medicines to develop and how to develop them. We examine the factors that are at the tipping point.
authors.affiliation: Collegeville, Pennsylvania, USA.
authors.forename: P
authors.initials: P
authors.lastname: Honig
authors.affiliation: Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
authors.forename: S-M
authors.initials: SM
authors.lastname: Huang
mesh_terms: D015195:Drug Design; D004341:Drug Evaluation / Q000379:methods; D004345:Drug Industry / Q000639:trends*; D006801:Humans; D004364:Pharmaceutical Preparations; D012106:Research / Q000639:trends*
chemical_list: D004364:Pharmaceutical Preparations